Search

Your search keyword '"Colbert LE"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Colbert LE" Remove constraint Author: "Colbert LE"
67 results on '"Colbert LE"'

Search Results

1. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer

2. Protocol for culturing patient-derived organoids of cervical cancer.

3. Genomic Biomarkers Predict Response to Combined ATR Inhibition and Radiotherapy.

4. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation.

5. Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.

7. Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers.

8. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic.

9. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.

10. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities.

11. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.

12. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.

13. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring.

14. Serial Genotyping of the Human Papillomavirus in Cervical Cancer: An Insight Into Virome Dynamics During Chemoradiation Therapy.

15. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.

16. Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women.

17. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors.

18. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer.

19. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.

20. An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check.

21. Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy.

22. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment.

23. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.

24. Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer.

25. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.

26. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16 + Cancers.

27. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies.

28. Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?

29. National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non-Small Cell Lung Cancer.

30. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers.

31. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.

32. Does a Custom Electronic Health Record Alert System Improve Physician Compliance With National Quality Measures for Palliative Bone Metastasis Radiotherapy?

33. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation.

34. Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice.

35. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image Guided Stereotactic Body Radiation Therapy in the Abdomen.

36. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.

37. Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer.

39. Microbiome factors in HPV-driven carcinogenesis and cancers.

40. Cancer Research after COVID-19: Where Do We Go from Here?

41. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer.

42. Outcomes of ICU Admission of Patients With Progressive Metastatic Gastrointestinal Cancer.

43. Immunotherapy and Radiation.

44. Top Concerns of Radiation Oncology Trainees in 2019: Job Market, Board Examinations, and Residency Expansion.

45. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.

46. A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change.

47. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

48. Brachytherapy Training Survey of Radiation Oncology Residents.

49. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.

50. Dose escalation for locally advanced pancreatic cancer: How high can we go?

Catalog

Books, media, physical & digital resources